相关实验视频

Updated: Sep 20, 2025

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

完全可生物降解的树枝状体作为新型纳米药物用于粉样β诱导的神经毒性

Débora A Moreira¹, Eva D Carvalho², Frederico Ferreira-da-Silva³

¹i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal; FEUP - Faculdade de Engenharia da Universidade do Porto, R. Dr. Roberto Frias s/n, 4200-465 Porto, Portugal.

Journal of controlled release : official journal of the Controlled Release Society

|May 23, 2025

概括

可生物降解的树枝状体显示出对阿尔茨海默病 (AD) 治疗的希望. 一种带正电荷的树脂分子,fbB,有效地抑制了有毒的粉样β (Aβ) 寡合体对神经元的损害,提供了新的治疗途径.

科学领域:

神经科学和纳米技术
生物化学和高分子科学生物化学和高分子科学

背景情况:

阿尔茨海默病 (AD) 是导致痴呆的主要原因,其特点是粉样β (Aβ) 聚合.
目前用于AD的纳米药物在生理条件下缺乏生物降解性.
登德里默具有可调节的特性,但需要生物可降解的设计用于治疗应用.

研究的目的:

为了评估可生物降解的Poly ((乙烯糖醇) - 酸 - 三乙烯糖醇乙 (PEG-GATGE) 阻断共聚合物的治疗潜力,针对Aβ (1-42) .
研究正 (fbB) 和负 (fbBz) 电荷的树枝状体对Aβ纤维化和神经毒性的影响.
评估这些新型树突体在神经元培养中的神经保护能力.

主要方法:

在fbB和fbBz树枝体的存在下研究了Aβ (1-42) 纤维化动力学,二次结构和总体形态学.
评估了与预先形成的Aβ纤维素的树枝膜相互作用.
在海马神经元培养物中评估了树突体对Aβ寡合体的神经保护作用.

主要成果:

这两种fbB和fbBz树状体都以比例依赖的方式调节了Aβ (1-42) 纤维化.
丹德里默与预先形成的Aβ纤维素发生相互作用.
只有带正电荷的fbB树状分子才能有效地阻止有毒的Aβ寡合体与神经元的结合.

结论:

可生物降解的PEG-GATGE树突体对阿尔茨海默病具有显著的治疗潜力.
带正电荷的fbB树突体表现出针对Aβ寡毒性的特定神经保护性质.
这一类可生物降解的树枝状体代表了在神经退行性疾病中开发新型纳米药物的有希望的途径.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.可生物降解的树枝状体.抑制剂的抑制剂纳米医学是一种纳米医学.纳米结构是一种纳米结构.神经保护作用神经保护作用

更多相关视频

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...